These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity. Berkel AI, Henle W, Henle G, Ersoy F, Sanal O, Klein G, Yeğin O. Kroc Found Ser; 1985 Dec; 19():287-300. PubMed ID: 2999343 [Abstract] [Full Text] [Related]
3. Immune deficiency in the X-linked lymphoproliferative syndrome. II. Immunoregulatory T cell defects. Lindsten T, Seeley JK, Ballow M, Sakamoto K, St Onge S, Yetz J, Aman P, Purtilo DT. J Immunol; 1982 Dec; 129(6):2536-40. PubMed ID: 6292291 [Abstract] [Full Text] [Related]
4. Cellular immune defects to Epstein-Barr virus-determined antigens in young males. Masucci MG, Szigeti R, Ernberg I, Masucci G, Klein G, Chessels J, Sieff C, Lie S, Glomstein A, Businco L, Henle W, Henle G, Pearson G, Sakamoto K, Purtilo DT. Cancer Res; 1981 Nov; 41(11 Pt 1):4284-91. PubMed ID: 6171337 [Abstract] [Full Text] [Related]
5. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases. Joncas JH, Wills A, Reece E, Fox Z. Can Med Assoc J; 1981 Oct 15; 125(8):845-9. PubMed ID: 6272957 [Abstract] [Full Text] [Related]
6. Abnormal anti-Epstein Barr virus antibodies in carriers of the X-linked lymphoproliferative syndrome and in females at risk. Sakamoto K, Seeley JK, Lindsten T, Sexton J, Yetz J, Ballow M, Purtilo DT. J Immunol; 1982 Feb 15; 128(2):904-7. PubMed ID: 6274962 [Abstract] [Full Text] [Related]
7. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients. Purtilo DT. AIDS Res; 1986 Dec 15; 2 Suppl 1():S177-81. PubMed ID: 2435295 [Abstract] [Full Text] [Related]
8. Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease. Grierson HL, Skare J, Hawk J, Pauza M, Purtilo DT. Am J Med Genet; 1991 Sep 01; 40(3):294-7. PubMed ID: 1683154 [Abstract] [Full Text] [Related]
9. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens. Masucci G, Mellstedt H, Masucci MG, Szigeti R, Ernberg I, Björkholm M, Tsukuda K, Henle G, Henle W, Pearson G. Cancer Res; 1984 Mar 01; 44(3):1288-300. PubMed ID: 6318984 [Abstract] [Full Text] [Related]
11. Immunodeficiency as a factor in lymphomagenesis. Purtilo DT, Sakamoto K. Perspect Pediatr Pathol; 1984 Mar 01; 8(2):181-91. PubMed ID: 6330665 [Abstract] [Full Text] [Related]
12. Epstein-Barr virus (EBV) and X-linked lymphoproliferative syndrome (XLP). Tatsumi E, Purtilo DT. AIDS Res; 1986 Dec 01; 2 Suppl 1():S109-13. PubMed ID: 3030340 [Abstract] [Full Text] [Related]
13. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease. Dolcetti R, Frisan T, Sjöberg J, De Campos-Lima PO, Pisa P, De Re V, Gloghini A, Rizzo S, Masucci MG, Boiocchi M. Cancer Res; 1995 Aug 15; 55(16):3675-81. PubMed ID: 7627978 [Abstract] [Full Text] [Related]
14. Epstein-Barr virus-induced diseases in the X-linked lymphoproliferative syndrome and related disorders. Purtilo DT. Biomed Pharmacother; 1985 Aug 15; 39(2):52-8. PubMed ID: 2990590 [Abstract] [Full Text] [Related]
15. Quantitative Epstein-Barr virus (EBV) serology in lung transplant recipients with primary EBV infection and/or post-transplant lymphoproliferative disease. Verschuuren E, van der Bij W, de Boer W, Timens W, Middeldorp J, The TH. J Med Virol; 2003 Feb 15; 69(2):258-66. PubMed ID: 12683416 [Abstract] [Full Text] [Related]
16. [Epstein-Barr virus-specific immunity in asymptomatic carriers of human T-cell leukemia virus type 1]. Kwon KW. Hokkaido Igaku Zasshi; 1995 Mar 15; 70(2):315-28. PubMed ID: 7774883 [Abstract] [Full Text] [Related]
17. X-linked lymphoproliferative syndrome. An immunodeficiency disorder with acquired agammaglobulinemia, fatal infectious mononucleosis, or malignant lymphoma. Purtilo DT. Arch Pathol Lab Med; 1981 Mar 15; 105(3):119-21. PubMed ID: 6894075 [Abstract] [Full Text] [Related]
18. [X-chromosomal recessively inherited lymphoproliferative syndrome. An analysis of EBV-induced immune deficiency]. Kammermeier-Schmidt U, Weiss M, Belohradsky BH. Monatsschr Kinderheilkd; 1993 Mar 15; 141(3):201-6. PubMed ID: 8386321 [Abstract] [Full Text] [Related]
19. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation. Nolte A, Buhmann R, Straka C, Emmerich B, Hallek M. Bone Marrow Transplant; 1998 May 15; 21(9):909-16. PubMed ID: 9613783 [Abstract] [Full Text] [Related]
20. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults. Suzuki K, Ohshima K, Karube K, Suzumiya J, Ohga S, Ishihara S, Tamura K, Kikuchi M. Int J Oncol; 2004 May 15; 24(5):1165-74. PubMed ID: 15067338 [Abstract] [Full Text] [Related] Page: [Next] [New Search]